Integrative analysis of genome-wide loss of heterozygosity and monoallelic expression at nucleotide resolution reveals disrupted pathways in triple-negative breast cancer

Genome Research

Volumn 22, Issue 10, 2012, Pages 1995-2007

  Ha, Gavin ^a,b   Roth, Andrew ^a,b   Lai, Daniel ^b   Bashashati, Ali ^a   Ding, Jiarui ^a,b   Goya, Rodrigo ^a,b   Giuliany, Ryan ^a,b   Rosner, Jamie ^a   Oloumi, Arusha ^a   Shumansky, Karey ^a   Chin, Suet Feung ^c   Turashvili, Gulisa ^a   Hirst, Martin ^a   Caldas, Carlos ^c   Marra, Marco A ^a   Aparicio, Samuel ^a,b   Shah, Sohrab P ^a,b  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; NUCLEOTIDE; TRANSCRIPTOME;

ALLELE; ARTICLE; BASE PAIRING; CELL CYCLE; CLINICAL ARTICLE; COHORT ANALYSIS; COPY NUMBER VARIATION; CYTOSKELETON; EPIGENETICS; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENOME ANALYSIS; HETEROZYGOSITY LOSS; HOMOLOGOUS RECOMBINATION; HUMAN; KARYOTYPE; MISSENSE MUTATION; NONSENSE MUTATION; ONCOGENE; PRIORITY JOURNAL; RNA SEQUENCE; SOMATIC MUTATION; TRIPLE NEGATIVE BREAST CANCER; TUMOR SUPPRESSOR GENE;

ALLELES; ALLELIC IMBALANCE; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE FREQUENCY; GENE REGULATORY NETWORKS; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LOSS OF HETEROZYGOSITY; MODELS, STATISTICAL; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84867164956     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.137570.112     Document Type: Article

References (48)

1. Bengtsson H, Neuvial P, Speed TP. 2010. Tumorboost: Normalization of allele-specific tumor copy numbers from a single pair of tumor-normal genotyping microarrays. BMC Bioinformatics 11: 245. doi: 10.1186/1471-2105-11-245.
2. Berger AH, Knudson AG, Pandolfi PP. 2011. A continuum model for tumour suppression. Nature 476: 163-169.
3. Beroukhim R, Lin M, Park Y, Hao K, Zhao X, Garraway LA, Fox EA, Hochberg EP, Mellinghoff IK, Hofer MD, et al. 2006. Inferring loss-of-heterozygosity from unpaired tumors using high-density oligonucleotide SNP arrays. PLoS Comput Biol 2: e41. doi: 10.1371/journal.pcbi.0020041.
4. Boeva V, Popova T, Bleakley K, Chiche P, Cappo J, Schleiermacher G, Janoueix-Lerosey I, Delattre O, Barillot E. 2011. Control-FREEC: A tool for assessing copy number and allelic content using next generation sequencing data. Bioinformatics 28: 423-425.
5. Bowtell DD. 2010. The genesis and evolution of high-grade serous ovarian cancer. Nat Rev Cancer 10: 803-808.
6. Cancer Genome Atlas Research Network. 2011. Integrated genomic analyses of ovarian carcinoma. Nature 474: 609-615.
7. Cingolani P. 2012. snpEff: Variant effect prediction. http://snpeff.sourceforge.net.
8. Colella S, Yau C, Taylor JM, Mirza G, Butler H, Clouston P, Bassett AS, Seller A, Holmes CC, Ragoussis J, et al. 2007. QuantiSNP: An objective Bayes hidden-Markov model to detect and accurately map copy number variation using snp genotyping data. Nucleic Acids Res 35: 2013-2025. (Pubitemid 47061667)
9. Curtis C, Shah SP, Chin S-F, Turashvili G, Rueda OM, Dunning MJ, Speed D, Lynch AG, Samarajiwa S, Yuan Y, et al. 2012. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486: 346-352.
10. Date O, Katsura M, Ishida M, Yoshihara T, Kinomura A, Sueda T, Miyagawa K. 2006. Haploinsufficiency of rad51b causes centrosome fragmentation and aneuploidy in human cells. Cancer Res 66: 6018-6024.
11. Dewal N, Hu Y, Freedman ML, Laframboise T, Pe'er I. 2011. Calling amplified haplotypes in next generation tumor sequence data. Genome Res 22: 362-374.
12. Ding L, Getz G, Wheeler DA, Mardis ER, McLellan MD, Cibulskis K, Sougnez C, Greulich H, Muzny DM, Morgan MB, et al. 2008. Somatic mutations affect key pathways in lung adenocarcinoma. Nature 455: 1069-1075.
13. Ding J, Bashashati A, Roth A, Oloumi A, Tse K, Zeng T, Haffari G, Hirst M, Marra MA, Condon A, et al. 2012. Feature-based classifiers for somatic mutation detection in tumour-normal paired sequencing data. Bioinformatics 28: 167-175.
14. Dutt A, Beroukhim R. 2007. Single nucleotide polymorphism array analysis of cancer. Curr Opin Oncol 19: 43-49. (Pubitemid 44885599)
15. Goya R, Sun MGF, Morin RD, Leung G, Ha G, Wiegand KC, Senz J, Crisan A, Marra MA, Hirst M, et al. 2010. SNVMix: Predicting single nucleotide variants from next-generation sequencing of tumors. Bioinformatics 26: 730-736.
16. Greenman CD, Bignell G, Butler A, Edkins S, Hinton J, Beare D, Swamy S, Santarius T, Chen L, Widaa S, et al. 2010. Picnic: An algorithm to predict absolute allelic copy number variation with microarray cancer data. Biostatistics 11: 164-175.
17. Greenman CD, Pleasance ED, Newman S, Yang F, Fu B, Nik-Zainal S, Jones D, Lau KW, Carter N, Edwards PAW, et al. 2012. Estimation of rearrangement phylogeny for cancer genomes. Genome Res 22: 346-361.
18. Hou Y, Song L, Zhu P, Zhang B, Tao Y, Xu X, Li F, Wu K, Liang J, Shao D, et al. 2012. Single-cell exome sequencing and monoclonal evolution of a JAK2-negative myeloproliferative neoplasm. Cell 148: 873-885.
19. Jirtle RL. 1999. Genomic imprinting and cancer. Exp Cell Res 248: 18-24. (Pubitemid 29393925)
20. LaFramboise T. 2009. Single nucleotide polymorphism arrays: A decade of biological, computational and technological advances. Nucleic Acids Res 37: 4181-4193.
21. LaFramboise T, Weir BA, Zhao X, Beroukhim R, Li C, Harrington D, Sellers WR, Meyerson M. 2005. Allele-specific amplification in cancer revealed by SNP array analysis. PLoS Comput Biol 1: e65. doi: 10.1371/journal.pcbi.0010065.
22. Laframboise T, Harrington D, Weir BA. 2007. PLASQ: A generalized linear model-based procedure to determine allelic dosage in cancer cells from SNP array data. Biostatistics 8: 323-336. (Pubitemid 46569593)
23. Li H, Durbin R. 2009. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25: 1754-1760.
24. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R, Subgroup GPDP, et al. 2009. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25: 2078-2079.
25. Li A, Liu Z, Lezon-Geyda K, Sarkar S, Lannin D, Schulz V, Krop I, Winer E, Harris L, Tuck D, et al. 2011. GPHMM: An integrated hidden Markov model for identification of copy number alteration and loss of heterozygosity in complex tumor samples using whole genome SNP arrays. Nucleic Acids Res 39: 4928-4941.
26. Lin M, Wei L-J, Sellers WR, Lieberfarb M, Wong WH, Li C. 2004. dChipSNP: Significance curve and clustering of SNP-array-based loss-of-heterozygosity data. Bioinformatics 20: 1233-1240. (Pubitemid 38807579)
27. Mardis ER, Wilson RK. 2009. Cancer genome sequencing: A review. Hum Mol Genet 18: R163-R168.
28. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly M, et al. 2010. The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 20: 1297-1303.
29. Merico D, Isserlin R, Stueker O, Emili A, Bader GD. 2010. Enrichment Map: A network-based method for gene-set enrichment visualization and interpretation. PLoS ONE 5: e13984. doi: 10.1371/journal.pone.0013984.
30. Närvä E, Autio R, Rahkonen N, Kong L, Harrison N, Kitsberg D, Borghese L, Itskovitz-Eldor J, Rasool O, Dvorak P, et al. 2010. High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity. Nat Biotechnol 28: 371-377.
31. Navin N, Kendall J, Troge J, Andrews P, Rodgers L, McIndoo J, Cook K, Stepansky A, Levy D, Esposito D, et al. 2011. Tumour evolution inferred by single-cell sequencing. Nature 472: 90-94.
32. Pastinen T, Hudson TJ. 2004. Cis-acting regulatory variation in the human genome. Science 306: 647-650. (Pubitemid 39440905)
33. Pleasance ED, Cheetham RK, Stephens PJ, McBride DJ, Humphray SJ, Greenman CD, Varela I, Lin M-L, Ordóñez GR, Bignell GR, et al. 2010a. A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 463: 191-196.
34. Pleasance ED, Stephens PJ, O'Meara S, McBride DJ, Meynert A, Jones D, Lin M-L, Beare D, Lau KW, Greenman C, et al. 2010b. A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 463: 184-190.
35. Roth A, Morin R, Ding J, Crisan A, Ha G, Giuliany R, Bashashati A, Hirst M, Turashvili G, Oloumi A, et al. 2012. JointSNVMix: A probabilistic model for accurate detection of somatic mutations in normal/tumour paired next generation sequencing data. Bioinformatics 28: 907-913.
36. Sathirapongsasuti JF, Lee H, Horst BA, Brunner G, Cochran AJ, Binder S, Quackenbush J, Nelson SF. 2011. Exome sequencing-based copynumber variation and loss of heterozygosity detection: ExomeCNV. Bioinformatics 27: 2648-2654.
37. Shah SP, Morin RD, Khattra J, Prentice L, Pugh T, Burleigh A, Delaney A, Gelmon K, Guliany R, Senz J, et al. 2009. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature 461: 809-813.
38. Shah SP, Roth A, Goya R, Oloumi A, Ha G, Zhao Y, Turashvili G, Ding J, Tse K, Haffari G, et al. 2012. The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature 486: 395-399.
39. Smoot ME, Ono K, Ruscheinski J, Wang PL, Ideker T. 2011. Cytoscape 2.8: New features for data integration and network visualization. Bioinformatics 27: 431-432.
40. Staaf J, Vallon-Christersson J, Lindgren D, Juliusson G, Rosenquist R, Höglund M, Borg A, Ringnér M. 2008. Normalization of Illumina Infinium whole-genome SNP data improves copy number estimates and allelic intensity ratios. BMC Bioinformatics 9: 409. doi: 10.1186/1471-2105-9-409.
41. Stratton MR, Campbell PJ, Futreal PA. 2009. The cancer genome. Nature 458: 719-724.
42. Thacker J, Zdzienicka MZ. 2003. The mammalian XRCC genes: Their roles DNA repair and genetic stability. DNA Repair (Amst) 2: 655-672. (Pubitemid 36588757)
43. Turner CE. 2000. Paxillin and focal adhesion signalling. Nat Cell Biol 2: 231-236.
44. Van Loo P, Nordgard SH, Lingjærde OC, Russnes HG, Rye IH, Sun W, Weigman VJ, Marynen P, Zetterberg A, Naume B, et al. 2010. Allele-specific copy number analysis of tumors. Proc Natl Acad Sci 107: 16910-16915.
45. Wu G, Feng X, Stein L. 2010. A human functional protein interaction network and its application to cancer data analysis. Genome Biol 11: R53. doi: 10.1186/gb-2010-11-5-r53.
46. Xu X, Hou Y, Yin X, Bao L, Tang A, Song L, Li F, Tsang S, Wu K, Wu H, et 2012. Single-cell exome sequencing reveals single-nucleotide mutation characteristics of a kidney tumor. Cell 148: 886-895.
47. Yau C, Mouradov D, Jorissen RN, Colella S, Mirza G, Steers G, Harris A, Ragoussis J, Sieber O, Holmes CC, et al. 2010. A statistical approach detecting genomic aberrations in heterogeneous tumor samples from single nucleotide polymorphism genotyping data. Genome Biol 11: R92. doi: 10.1186/gb-2010-11-9- r92.
48. Zhao Q, Kirkness EF, Caballero OL, Galante PA, Parmigiani RB, Edsall L, Kuan S, Ye Z, Levy S, Vasconcelos AT, et al. 2010. Systematic detection putative tumor suppressor genes through the combined use of exome and transcriptome sequencing. Genome Biol 11: R114. doi: 10.1186/gb-2010-11-11-r114.